What is he best known for?
The fields of study he is best known for:
- Gene
- Cancer
- Internal medicine
Lymphoma, Cancer research, Pathology, Diffuse large B-cell lymphoma and Mantle cell lymphoma are his primary areas of study.
His studies deal with areas such as Survival analysis and Gene expression profiling as well as Lymphoma.
His research integrates issues of Chromosomal translocation, Mutation, Immunology, Molecular biology and Chronic lymphocytic leukemia in his study of Cancer research.
His Diffuse large B-cell lymphoma study integrates concerns from other disciplines, such as Germinal center, BCL6, Concordance, Immunophenotyping and Tissue microarray.
His Mantle cell lymphoma study combines topics from a wide range of disciplines, such as Nonsense mutation, Missense mutation, Apoptosis, Gene and Cyclin D1.
His biological study spans a wide range of topics, including Gastroenterology, Surgery and Oncology.
His most cited work include:
- Signatures of mutational processes in human cancer (5372 citations)
- The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma (3077 citations)
- The 2016 revision of the World Health Organization classification of lymphoid neoplasms (3041 citations)
What are the main themes of his work throughout his whole career to date?
Elias Campo mainly focuses on Cancer research, Lymphoma, Pathology, Internal medicine and Chronic lymphocytic leukemia.
His research on Cancer research also deals with topics like
- CD5 most often made with reference to Mantle cell lymphoma,
- Gene, which have a strong connection to Molecular biology.
His Lymphoma research integrates issues from Immunophenotyping, B cell and Gene expression profiling.
Many of his studies involve connections with topics such as Cancer and Pathology.
His studies deal with areas such as Gastroenterology and Oncology as well as Internal medicine.
The study incorporates disciplines such as Epigenetics and Disease in addition to Chronic lymphocytic leukemia.
He most often published in these fields:
- Cancer research (34.58%)
- Lymphoma (31.07%)
- Pathology (30.37%)
What were the highlights of his more recent work (between 2016-2021)?
- Cancer research (34.58%)
- Chronic lymphocytic leukemia (18.81%)
- Internal medicine (20.68%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Cancer research, Chronic lymphocytic leukemia, Internal medicine, Lymphoma and Oncology.
His study in Cancer research is interdisciplinary in nature, drawing from both DNA methylation, Mutation, Gene, Mantle cell lymphoma and Germinal center.
His Chronic lymphocytic leukemia research is multidisciplinary, incorporating perspectives in Cancer, Epigenetics and Disease.
His work on Follicular lymphoma, Hematology and Confounding as part of general Internal medicine study is frequently linked to In patient, therefore connecting diverse disciplines of science.
His work in Lymphoma covers topics such as Gene expression profiling which are related to areas like CDKN2A.
His Oncology study combines topics in areas such as International Prognostic Index and Clinical trial.
Between 2016 and 2021, his most popular works were:
- Pan-cancer analysis of whole genomes (538 citations)
- Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma (524 citations)
- Genomic and Functional Approaches to Understanding Cancer Aneuploidy (296 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Cancer
- Internal medicine
Elias Campo spends much of his time researching Cancer research, Lymphoma, Chronic lymphocytic leukemia, Gene and Leukemia.
His research integrates issues of Pathogenesis, DNA methylation, Mantle cell lymphoma, Transcription factor and microRNA in his study of Cancer research.
The Lymphoma portion of his research involves studies in Pathology and Immunology.
His Pathology research includes themes of Fever of unknown origin and Whole Transcriptome Sequencing.
His Chronic lymphocytic leukemia research incorporates themes from Somatic hypermutation, breakpoint cluster region, Antibody, Retinoic acid and Epigenome.
The Leukemia study combines topics in areas such as Oncology, Chemokine, Chemokine secretion, Tumor microenvironment and Lymph node.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
